SIBO Treatment That Actually Works: A Root-Cause Approach for Scottsdale Patients

There’s a pattern Dr. MaryK Geyer sees consistently: a woman in her early to mid-40s, gut issues she’s managed for years, suddenly getting worse. Bloating that used to be occasional is now constant. She’s done Rifaximin. Maybe twice. She felt better for a few weeks, and then it all came back. Around the same time, her hormones started shifting. Her sleep changed. She’s been to a GI specialist who told her it’s IBS. She knows it’s not IBS.

The SIBO-hormone connection is one of the most consistently overlooked drivers of treatment failure in women. Treating the bacterial overgrowth without touching what allowed it to develop, and what keeps allowing it to come back, is why so many women cycle through protocols without resolution. Here’s what a complete approach actually looks like.

Why Women Get SIBO Differently: The Hormonal Context That Changes Everything

This isn’t just about gut bacteria. It never was.

How Estrogen, Progesterone, and Thyroid Hormone Affect Gut Motility

Progesterone slows gut motility. That’s why bloating reliably spikes in the week before your period, higher progesterone in the luteal phase moves things through more slowly. In perimenopause, progesterone drops first and drops fast. The result is a gut that’s slower, less organized in how it clears the small intestine, and more susceptible to bacterial accumulation in places bacteria don’t belong.

Estrogen dominance, too much estrogen relative to a declining progesterone, impairs bile flow and liver-based estrogen clearance, which changes the gut environment. And thyroid hormone, which most conventional labs check with a single TSH number, directly regulates gut transit time. Subclinical hypothyroidism is  a common and consistently missed driver of SIBO in women in their 40s and 50s.

Then there’s cortisol. Chronic stress suppresses stomach acid production, which is your first line of defense against bacteria moving where they shouldn’t. High cortisol also directly impairs the migrating motor complex, the mechanism responsible for sweeping bacteria out of the small intestine between meals. In the Scottsdale population, which runs high-achieving, high-cortisol, high-ambient-heat as a kind of default, adrenal dysregulation is almost never an afterthought.

The Food Poisoning Trigger, and Why Some Women and Not Others

Post-infectious SIBO is more common than most people know. A bad case of food poisoning like Campylobacter, Salmonella, even a stomach virus can trigger an autoimmune response that damages the intestinal cells and nerve fibers that drive the migrating motor complex. This is detectable through anti-vinculin and anti-CdtB antibodies, tests most GI workups don’t include.

Why some women develop lasting SIBO after an infection and others don’t comes down partly to their immune response at the time, and partly to their hormonal status. Perimenopause is a period of immune dysregulation, the immune system responds differently when estrogen and progesterone are fluctuating. That increases susceptibility to post-infectious autoimmune gut damage in ways that are specific to this life stage.

What SIBO Treatment Looks Like When Hormones Are Part of the Picture

The integrated assessment is what changes everything here.

Running the Gut and Hormone Workup at the Same Time

Conventional medicine separates these: GI appointment for gut symptoms, OB/GYN or endocrinology for hormones. That division is logical for billing purposes. It’s not logical for the actual patient, whose gut and hormones are running on the same physiology.

At Empower Integrative Health, Dr. MaryK Geyer runs both concurrently. The comprehensive intake includes a DUTCH complete hormone panel alongside the GI workup, breath test for SIBO type identification (hydrogen, methane, or hydrogen sulfide), stool mapping, zonulin for intestinal permeability, and calprotectin for inflammation markers. Four-point saliva cortisol runs alongside the gut panel. Full thyroid, not just TSH, but Free T3, Free T4, and thyroid antibodies is part of the same visit.

What this changes is everything downstream. The antimicrobial protocol, the prokinetic selection, the dietary approach, and the timeline are all modified when you know whether the woman you’re treating has high cortisol suppressing her MMC function, or subclinical Hashimoto’s slowing her gut transit, or estrogen dominance impairing her liver’s ability to clear hormones that feed back into gut health. Treating SIBO in that context without addressing those drivers is treating the symptom of the symptom.

The Three-Phase Protocol (Done in the Right Order)

Most SIBO protocols skip straight to eradication. That’s the second phase. Here’s why sequence matters.

Phase one is gut environment stabilization, not eradication. Aggressive antimicrobial treatment on an already inflamed, reactive gut increases die-off symptoms and can make things temporarily worse. 

Before eradication, you want to calm the environment: reduce fermentation through targeted dietary changes (low-FODMAP, elemental, or specific carbohydrate diet depending on severity), disrupt the biofilm bacteria form to protect themselves from treatment, and begin supporting stomach acid and digestive enzyme production. For women with concurrent hormonal issues, initial adrenal and thyroid support begins here too.

Phase two is targeted eradication matched to the breath test result. Hydrogen-dominant SIBO responds well to herbal antimicrobials like oregano oil, berberine, and allicin in a rotating four-to-six-week protocol. Methane-dominant SIBO, officially reclassified as IMO, or Intestinal Methanogen Overgrowth, involves archaea rather than bacteria and requires a different antimicrobial approach entirely. 

Many patients fail their first round of Rifaximin because they have methane-dominant SIBO, which requires a dual protocol. Hydrogen sulfide SIBO requires specific testing beyond a standard breath test and its own targeted protocol. Dr. MaryK Geyer uses both herbal and pharmaceutical antimicrobials when the clinical picture calls for them, this is integrative medicine, not ideology.

Phase three is where most protocols stop too early. This is root cause and relapse prevention, the phase that determines whether treatment holds. Prokinetic support restores migrating motor complex function: low-dose naltrexone, motility-supporting botanicals, dietary spacing between meals to allow MMC waves to complete. 

Gut microbiome rehabilitation starts here, not during eradication, probiotic timing matters, and introducing Lactobacillus and Bifidobacterium strains during an active antimicrobial phase is generally counterproductive. Intestinal permeability repair: L-glutamine, zinc carnosine, collagen. And the hormonal correction that makes the whole thing hold.

What Most SIBO Treatment Gets Wrong for Women

The GI literature that forms the basis of most SIBO treatment protocols historically undercounts women, and almost none of it stratifies by hormonal status. That’s not a criticism of GI medicine; it’s a gap in the research that has real clinical consequences for women in perimenopause getting treated with protocols designed for a much broader population.

The One-Size Protocol Problem

Treating a perimenopausal woman’s SIBO the same way you’d treat post-infectious SIBO in a 30-year-old is one of the most common reasons women relapse. The underlying drivers are different. 

The hormonal context is different. The adrenal picture is different. And the dietary piece is worth examining too: low-FODMAP is the most commonly recommended dietary intervention for SIBO, and it’s a reasonable short-term symptom management tool. But for women with estrogen dominance, indiscriminately removing cruciferous vegetables, which are frequently restricted on low-FODMAP, eliminates a critical source of DIM and other compounds the liver uses to clear excess estrogen. Managing one problem while quietly worsening another.

What Relapse Prevention Actually Looks Like

Relapse prevention in this population isn’t a supplement to take and a diet to maintain indefinitely. It’s an ongoing correction of the physiology that made the gut environment hospitable to bacterial overgrowth in the first place.

For women with perimenopause-related SIBO, that means hormone balancing as an ongoing part of integrative women’s health care, progesterone support directly supports gut motility. Adrenal support, cortisol management through adaptogenic botanicals, stress physiology work, sleep hygiene that actually gets addressed rather than noted and dismissed. 

Because cortisol’s effect on MMC function is measurable and reversible. Annual or biannual GI reassessment alongside hormone monitoring, because the same physiological shifts that triggered SIBO the first time will continue if they’re not managed.

Some patients need this longer-term support. Most eventually reach a stable point where the gut is functioning well and the hormonal picture is managed. That’s what resolution looks like in complex presentations, not a course of antibiotics and a clear breath test, but a chronic care model that treats the person, not just the bacteria.

SIBO Is Treatable.

The frustrating part isn’t that it can’t be resolved, it’s that most protocols stop before they get to the part that actually makes it hold.

If you’ve done the protocol and you’re back where you started, the problem isn’t that you haven’t found the right antibiotic. It’s that the underlying driver hasn’t been touched. 

For women in perimenopause, that driver almost always has something to do with hormones, adrenals, or thyroid, and often all three. Treating the gut without that context is addressing the output of a system that’s still broken.

If you’re in Scottsdale and you’re ready to do this as a whole-system problem rather than a GI problem, that’s the conversation Dr. MaryK Geyer’s practice is built around. The 90-minute intake exists so there’s enough time to actually understand what’s going on before anything is prescribed. Learn about Dr. MaryK Geyer’s GI and gut health approach in Scottsdale